These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6475776)

  • 1. Effects of oral mexiletine on left and right ventricular function.
    Stein J; Podrid P; Lown B
    Am J Cardiol; 1984 Sep; 54(6):575-8. PubMed ID: 6475776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antiarrhythmic agents on left ventricular function during exercise in patients with chronic left ventricular dysfunction.
    Takada Y; Isobe S; Okada M; Ando A; Nonokawa M; Inden Y; Tomita Y; Suzuki A; Hirai M; Murohara T
    Ann Nucl Med; 2004 May; 18(3):209-19. PubMed ID: 15233282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexiletine: long-term efficacy and hemodynamic actions in patients with ventricular arrhythmia.
    Sami M; Lisbona R
    Can J Cardiol; 1985; 1(4):251-8. PubMed ID: 2413974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of mexiletine on left ventricular function and relation to suppression of ventricular arrhythmia.
    Singh S; Klein R; Eisenberg B; Hughes E; Shand M; Doherty P
    Am J Cardiol; 1990 Nov; 66(17):1222-7. PubMed ID: 1700592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Ethmozine (moricizine HCl) on ventricular function using echocardiographic, hemodynamic and radionuclide assessments.
    Pratt CM; Podrid PJ; Seals AA; Young JB; Hession M; Lampert S; Quiñones M; Lown B
    Am J Cardiol; 1987 Oct; 60(11):73F-78F. PubMed ID: 3310589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mexiletine and tocainide: does response to one predict response to the other?
    Hession M; Blum R; Podrid PJ; Lampert S; Stein J; Lown B
    J Am Coll Cardiol; 1986 Feb; 7(2):338-43. PubMed ID: 3080508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral combination therapy with mexiletine and quinidine on left and right ventricular function.
    Sheldon RS; Duff HJ; Mitchell LB; Wyse DG; Manyari DE
    Am Heart J; 1988 May; 115(5):1030-6. PubMed ID: 3284310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
    Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography.
    Manyari DE; Kostuk WJ; Carruthers SG; Johnston DJ; Purves P
    Am J Cardiol; 1983 Feb; 51(3):427-33. PubMed ID: 6401908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in cardiac output determined by continuous-wave Doppler echocardiography during propafenone or mexiletine drug testing.
    Lange H; Lampert S; Sutton MS; Lown B
    Am J Cardiol; 1990 Feb; 65(7):458-62. PubMed ID: 2305684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of mexiletine.
    Shanks RG
    Am Heart J; 1984 May; 107(5 Pt 2):1065-71. PubMed ID: 6372422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.
    Chew CY; Collett J; Singh BN
    Drugs; 1979 Mar; 17(3):161-81. PubMed ID: 378646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of a new anti-arrhythmic agent, mexiletine (Kö 1173) in ischaemic heart disease.
    Saunamäki
    Cardiovasc Res; 1975 Nov; 9(6):788-92. PubMed ID: 1203917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of flecainide on left ventricular ejection fraction.
    Brembilla-Perrot B; Amor M; Auque F; Isaaz K; Terrier de la Chaise A; Bertrand A; Cherrier F; Pernot C
    Eur Heart J; 1987 Jul; 8(7):754-61. PubMed ID: 3115780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias].
    Rolli A; Bonatti V; Finardi A; Favaro L; Botti G
    G Ital Cardiol; 1981; 11(4):468-76. PubMed ID: 6169578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mexiletine in the treatment of ventricular arrhythmias.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mexiletine for ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1981 Apr; 47(4):895-902. PubMed ID: 6782850
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and clinical use of mexiletine.
    Fenster PE; Comess KA
    Pharmacotherapy; 1986; 6(1):1-9. PubMed ID: 3513138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.